The estimated $8.1 million transaction represented about 1% of fund assets at the end of the quarter. Destiny Wealth now owns 16,430 shares valued at $2.4 million, which is about 0.3% of the firm's ...
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. The ETF industry has long been ...
Ağaç ve Peyzaj A.Ş. üzerinden usulsüzlük yapıldığı ve ihaleye fesat karıştırıldığı iddiasıyla İBB'ye yeni operasyon ...
The two biotech ETF products with around $8 billion in assets are IBB and XBI. At $133.36 on February 17, the iShares Biotechnology ETF (IBB) had $8.58 billion in assets under management. The S&P SPDR ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an ...
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results